Rheumatology
661 – 670 of 1570
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
Cost-effectiveness of infliximab versus conventional combination treatment in methotrexate-refractory early rheumatoid arthritis: 2-year results of the register-enriched randomised controlled SWEFOT trial.
(
- Contribution to journal › Article
-
Mark
Comparing Five Year Out-Come in Two Cohorts of Patients with Early Rheumatoid Arthritis - A BARFOT Study.
(
- Contribution to journal › Article
-
Mark
Mood Disorders in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study
(
- Contribution to journal › Article
-
Mark
Current smoking status is a strong predictor of radiographic progression in early rheumatoid arthritis: results from the SWEFOT trial
(
- Contribution to journal › Article
-
Mark
Drug survival on TNF inhibitors in patients with rheumatoid arthritis comparison of adalimumab, etanercept and infliximab
(
- Contribution to journal › Article
-
Mark
Cartilage oligomeric matrix protein: a new promising biomarker of liver fibrosis in chronic hepatitis C
(
- Contribution to journal › Article
-
Mark
Type I interferon-mediated skewing of the serotonin synthesis is associated with severe disease in systemic lupus erythematosus.
(
- Contribution to journal › Article
-
Mark
Personal factors in systemic sclerosis and their coverage by patient-reported outcome measures
(
- Contribution to journal › Article
-
Mark
Hand function and performance of daily activities in systemic lupus erythematosus: a clinical study.
(
- Contribution to journal › Article
-
Mark
Safety of etoricoxib, celecoxib and non-selective NSAIDs in Ankylosing spondylitis and other Spondyloarthritis patients: A Swedish national population based cohort study.
(
- Contribution to journal › Article